Jointown Pharmaceutical Hits Day Low of CNY 4.89 Amid Price Pressure

Jointown Pharmaceutical Group Co., Ltd. experienced a notable decline today, with the stock dropping by 3.5% on March 23, 2026. The stock reached an intraday low of CNY 4.89, reflecting ongoing challenges in its market performance. Over the past week, Jointown has seen a decrease of 6.77%, while its monthly performance stands at a decline of 3.69%. In the context of the broader market, the China Shanghai Composite index also faced a downturn, with a 3.63% drop today. Year-to-date, Jointown's performance is down 3.13%, slightly better than the index's decline of 3.92%. However, the company has struggled significantly over the longer term, with a staggering 66.6% drop over the past three years and a 72.34% decline over five years. Despite these challenges, Jointown maintains a market capitalization of CNY 25,969 million and a price-to-earnings ratio of 8.00. The company has a dividend yield of 3.88%, which may provide some appeal to income-focused investors. However, its return on equity stands at 10.82%, indicating limited profitability relative to shareholder funds.